Antisense Therapeutics Limited - ROE
ATHJF
Price:
$0.012
Market Cap:
$5.57M
Antisense Therapeutics Limited (ATHJF) is an Australian biotechnology company dedicated to the research and development of innovative antisense pharmaceuticals. Its therapeutic pipeline includes two primary drug candidates. ATL1102, an antisense inhibitor targeting CD49d, is currently in Phase II clinical trials for a variety of inflammatory conditions, such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. The company's second candidate, ATL1103, is an advanced second-generation antisense medication. This drug works by blocking growth hormone receptor expression, which subsequently lowers levels of insulin-like growth factor-I (IGF-I) in the bloodstream, and has successfully c...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-09-08
Stock Exchange
OTC
Ticker
ATHJF
PE Ratio
[-1.20]
ROE
[-110.74%]
Current Ratio
[6.29]
Dividend Yield
[0%]
Enterprise Value
[1.12M]
Dividend History
The ROE as of June 2026 (TTM) for Antisense Therapeutics Limited (ATHJF) is -110.74%
According to Antisense Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is -110.74%. This represents a change of 84.72% compared to the average of -59.95% of the last 4 quarters.
Antisense Therapeutics Limited (ATHJF) Historical ROE (quarterly & annually)
How has ATHJF ROE performed in the past?
The mean historical ROE of Antisense Therapeutics Limited over the last ten years is -105.27%. The current -110.74% ROE has changed 5.20% with respect to the historical average. Over the past ten years (40 quarters), ATHJF's ROE was at its highest in in the June 2002 quarter at 0%. The ROE was at its lowest in in the June 2024 quarter at -76.64%.
Average
-105.27%
Median
-120.69%
Minimum
-149.16%
Maximum
-27.49%
Antisense Therapeutics Limited (ATHJF) ROE by Quarter and Year
Discovering the peaks and valleys of Antisense Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 314.97%
Maximum Annual ROE = -27.49%
Minimum Annual Increase = -651.09%
Minimum Annual ROE = -149.16%
| Year | ROE | Change |
|---|---|---|
| 2025 | -149.16% | 17.17% |
| 2024 | -127.30% | 11.59% |
| 2023 | -114.08% | 314.97% |
| 2022 | -27.49% | -80.47% |
| 2021 | -140.73% | 7.93% |
| 2020 | -130.40% | 24.43% |
| 2019 | -104.80% | 89.78% |
| 2018 | -55.22% | -62.85% |
| 2017 | -148.63% | 170.56% |
| 2016 | -54.93% | -651.09% |
Antisense Therapeutics Limited (ATHJF) Average ROE
How has ATHJF ROE performed in the past?
The current ROE of Antisense Therapeutics Limited (ATHJF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-130.18%
5-year avg
-111.75%
10-year avg
-105.27%
Antisense Therapeutics Limited (ATHJF) ROE vs. Peers
How is ATHJF’s ROE compared to its peers?
Antisense Therapeutics Limited’s ROE is greater than Biofrontera AG (-476.72%), greater than TPCO Holding Corp. (-91.05%), greater than Lifeist Wellness Inc. (-50.22%), greater than RAMM Pharma Corp. (-96.79%), greater than Vinergy Capital Inc. (-78.83%), less than Organicell Regenerative Medicine, Inc. (455.87%), greater than Together Pharma Ltd (-6.61%), greater than Simply Better Brands Corp. (-236.00%), less than Kadimastem Ltd (0.12%), greater than Yourgene Health Plc (-5.84%),
| Company | ROE | Market cap |
|---|---|---|
| -476.72% | $19.35M | |
| -91.05% | $20.12M | |
| -50.22% | $15.76M | |
| -96.79% | $15.16M | |
| -78.83% | $20.57M | |
| 455.87% | $19.97M | |
| -6.61% | $18.45M | |
| -236.00% | $14.81M | |
| 0.12% | $9.50M | |
| -5.84% | $20.67M |
Build a custom stock screener for Antisense Therapeutics Limited (ATHJF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antisense Therapeutics Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Antisense Therapeutics Limited (ATHJF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Antisense Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Antisense Therapeutics Limited's ROE?
How is the ROE calculated for Antisense Therapeutics Limited (ATHJF)?
What is the highest ROE for Antisense Therapeutics Limited (ATHJF)?
What is the 3-year average ROE for Antisense Therapeutics Limited (ATHJF)?
What is the 5-year average ROE for Antisense Therapeutics Limited (ATHJF)?
How does the current ROE for Antisense Therapeutics Limited (ATHJF) compare to its historical average?